Tasimelteon not checked

Vanda Pharmaceuticals · VEC-162

FollowEvery change as it happens, and a Monday email
Stage
in the US · approved in the EU
Next date
Phase 3 trial completes
Trials
2 active
11 in total · 3 in the EU

What this is

How it works
Melatonin Receptor Agonist FDA class
How it’s given
“Single daily dose, weight-based liquid suspension formulation.”In the company’s words, NCT06953869 on ClinicalTrials.gov
Tested for
Sleep Wake Disorders, Sleep Disorders, Circadian Rhythm, Chronobiology Disorders, Gene Mutations and Other Alterations Nec, Insomnia Disorder
Main trialPhase 3
“This is a double-blind, randomized, two-period crossover study to evaluate the efficacy and safety of a single oral dose of tasimelteon and matching placebo in male and female subjects with DSWPD and the CRY1Δ11 variant.”In the company’s words, NCT06701396 on ClinicalTrials.gov
Other names
VEC-162 · Hetlioz

Other drugs for Sleep Wake Disorders

All 2 drugs for Sleep Wake Disorders

Coming up1

Changes0

Last 90 days

No changes yet. We started recording changes on 6 Nov 2026.

Trials11

TrialPhaseCompletesWhat it tests
Phase 3Recruiting 30 Jun 2025 Evaluating the Effects of Tasimelteon Vs. Placebo in Delayed Sleep-Wake Phase Disorder (DSWPD) and the CRY1Δ11 Variant
Phase 3Recruiting Nov 2027 Evaluating the Effects of Tasimelteon vs. Placebo in Treating Pediatric Insomnia
Phase 3Completed 5 Mar 2018 Evaluating the Effects of Tasimelteon vs. Placebo on Jet Lag Type Insomnia
Phase 3Unknown 5 Dec 2024 Safety Study of Tasimelteon for Treatment of Non-24-Hour-Sleep-Wake Disorder in Blind Individuals With No Light Perception
Phase 3Unknown Jul 2025 Evaluating the Effects of Tasimelteon in Individuals With Autism Spectrum Disorder (ASD) and Sleep Disturbances
Phase 3Completed 4 Sep 2026 Evaluating the Effects of Tasimelteon vs. Placebo in Delayed Sleep-Wake Phase Disorder (DSWPD)
Phase 2/3Completed 19 Nov 2018 Evaluating the Effects of Tasimelteon vs Placebo on Sleep Disturbances in SMS
Phase 2Completed Nov 2017 A Proof of Concept Study to Evaluate the Effects of Tasimelteon and Placebo in Travelers With Jet Lag Disorder
Phase 1Completed 20 Dec 2017 Study of the Pharmacokinetics and Safety of Tasimelteon in Children and Adolescents
Phase 1Completed 28 Aug 2018 Evaluation of Next-Day Residual Effects of Tasimelteon Compared With Placebo and Active Control in Healthy Subjects
Phase 1Completed 15 Jun 2022 Bioequivalence Study Between Tasimelteon Capsule Formulation and Liquid Suspension Formulation in Healthy Volunteers
A trial in both registries shows both numbers.

About

Sources
ClinicalTrials.gov updated 18 Nov 2026 · EU trials register (CTIS) updated 18 Nov 2026 · openFDA updated 17 Nov 2026

Follow Tasimelteon

Following is part of Solo: you see every change to Tasimelteon the day it happens.

Solo

$49a month, excl. VAT

  • Follow up to 5 landscapes, companies or drugs
  • Every change, the day it happens
  • A Monday email with the week’s changes
Choose Solo

Free

$0no card

  • One landscape of your own, in full
  • The top 10 of everything else
Sign up free

Have an account? Sign in